Carbapenems (imipenem, meropenem, doripenem) are the mainstay of treatment for A. baumannii, though carbapenem-resistant Acinetobacter strains have increasingly ...

Thus, combination therapy with ampicillin–sulbactam and meropenem is effective against skin and soft tissue infection due to carbapenem-resistant A. baumannii.

Treatment of Acinetobacter Infections. Antibiotic therapy based on susceptibility testing. In patients with localized cellulitis or phlebitis associated with ...

6 июн. 2023 г. · Sulbactam/durlobactam is the first antibiotic approved to treat HABP and VABP caused by Acinetobacter. Results from the phase 3 ATTACK trial ...

11 апр. 2024 г. · Acinetobacter infections are generally treated with antibiotics. To identify the best antibiotic to treat a specific infection, healthcare ...

Minocycline and doxycycline are both available by intravenous infusion and minocycline is approved by the FDA for use in acinetobacter infections. In vitro ...

He was initially treated with vancomycin, imipenem-cilastatin, tobramycin, and micafungin. Infusions with crystalloids and norepinephrine were necessary. On the ...

27 янв. 2020 г. · A doctor may use other antibiotic treatments, such as beta-lactam antibiotics, or other antimicrobial drugs to treat the infection. Researchers ...

The authors found ampicillin/sulbactam at a maximum daily dose of 18 g in combination with a second drug to be the most effective option for reducing mortality.